- Home
- NPT vs TKNO Comparison
NPT vs TKNO Comparison
Compare NPT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | TKNO |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.5M | 138.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NPT | TKNO |
|---|---|---|
| Price | $20.38 | $2.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 457.4K | 242.3K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.65 |
| Revenue Next Year | N/A | $13.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $3.14 | $1.91 |
| 52 Week High | $22.38 | $7.48 |
Technical Indicators
Market Signals| Indicator | NPT | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 90.58 | 35.16 |
| Support Level | $4.42 | N/A |
| Resistance Level | N/A | $2.62 |
| Average True Range (ATR) | 1.91 | 0.18 |
| MACD | 1.59 | 0.07 |
| Stochastic Oscillator | 88.43 | 29.58 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.